Abstract: A battery connection structure includes a plurality of battery units connected in series. At least one battery unit is connected in series to other battery units through a temperature switch; the temperature switch includes a first connection member connected to a first electrode terminal of the battery unit and a second connection member connected to a second electrode terminal of the battery unit; at normal operating temperature, the first connection member and the second connection member are disconnected, and the first connection member and the second connection member are respectively connected to the two electrode terminals of the battery unit; when the temperature is higher than the normal operating temperature, the first connection member and/or the second connection member are/is deformed and disconnected from the corresponding electrode terminal(s) of the battery unit, and the first connection member and the second connection member are connected.

Abstract: A method for preparing a tumor-derived microparticle by a microwave includes the following steps: step 1, Lewis lung carcinoma (LLC) of a lung adenocarcinoma cell line is taken and then the LCC is cultured in a culture dish for more than 24 hours (h) to obtain cultured cells; step 2, microwave heating treatment is performed on the cultured cells obtained in step 1 to obtain treated cells; step 3, the treated cells obtained in step 2 are placed into a constant temperature incubator for cultivation for 24 h; and step 4, a supernatant of cells is collected from the culture dish cultured in step 3, and multiple centrifugation treatments is performed on the supernatant by using a density gradient centrifugation method to obtain a precipitate which is the tumor-derived microparticle TMPMW.

Abstract: The disclosure provides preparation methods of a solid-state battery and a battery array, and a solid-state battery. The above preparation method adopts powder sintering 3D printing manufacturing technology, which can increase the interfacial contact among different materials, and improve the contact interface between the electrode and the solid-state electrolyte, thereby obtaining a better ion conduction path. Through printing, annealing and cooling layer by layer, the internal stress, the interlayer effect and the interface effect are eliminated, and defects are reduced, which makes the structure of the prepared positive electrode, negative electrode, solid-state electrolyte and the entire solid-state battery more stable.

Abstract: The disclosure provides a Sense Amplifier (SA), a memory and a method for controlling the SA, and relates to the technical field of semiconductor memories. The SA includes: an amplifier module; an offset voltage storage unit electrically connected to the amplifier module and configured to store an offset voltage of the amplifier module in an offset elimination stage of the SA; and a load compensation unit electrically connected to the amplifier module and configured to compensate a difference between loads of the amplifier module in an amplification stage of the SA. The disclosure may improve an accuracy of reading data of the SA.

Abstract: A sense amplifier, a memory and a method for controlling the sense amplifier are provided. The sense amplifier includes: an amplification module, arranged to read data in a memory cell; and a control module, electrically connected to the amplification module. In a first offset compensation stage of the sense amplifier, the control module is arranged to configure the amplification module to include a first inverter and a second inverter, and each of the first inverter and the second inverter is an inverter an input terminal and an output terminal connected to each other; and in a second offset compensation stage of the sense amplifier, the control module is arranged to configure the amplification module to include a current mirror structure.

Abstract: The sense amplifier includes: an amplification module configured to amplify a voltage transmitted by a bit line or a reference bit line, when the sense amplifier is at an amplification stage; a first switch module configured to control the amplification module to be disconnected from the reference bit line, when the sense amplifier performs a read operation for the bit line and is at the amplification stage. In the disclosure, the power consumption of the sense amplifier may be reduced.

Abstract: The disclosure provides an energy storage battery system, including a battery cluster, a first communicating unit and a second communicating unit. The battery cluster includes at least one battery module, and the battery module includes at least one battery cell. The first communicating unit and the second communicating unit are both communicated with the battery cell. The first communicating unit is used to connect with an air extraction device, and the gas in the battery cell and the first communicating unit can be extracted using the air extraction device. The second communicating unit is used to connect with a low-pressure pump, and external cooling fluid can be transmitted to an interior of the battery cell using the low-pressure pump. The disclosure further provides a control method of battery thermal runaway.

Abstract: The disclosure provides an energy storage battery system, including a battery cluster and a first communicating unit. The battery cluster includes at least one battery module, and the battery module includes at least one battery cell. The first communicating unit is used to connect with a high-pressure pump, and external cooling fluid can be pressurized by the high-pressure pump and transmitted to the first communicating unit to cause the first communicating unit to burst, and after the first communicating unit bursts, the cooling fluid is sprayed to the battery cell. The disclosure further provides a control method of battery thermal runaway.

Abstract: The application discloses a pipeline annular self-traveling guide apparatus and a pipeline annular self-traveling guiding method. The pipeline annular self-traveling guide apparatus includes an inner annular groove and an outer annular groove. A first pipeline fixing part is configured on the inner annular groove, a second pipeline fixing part is configured on the outer annular groove, an annular bracket which is configured to rotate freely along a circumferential direction is correspondingly configured between the inner annular groove and the outer annular groove, a pipeline supporting roller group is configured on the annular bracket, and gaps for laying pipelines are reserved between a circumferential surface of the pipeline supporting roller and inner bottom surfaces of the inner annular groove and the outer annular groove.

Abstract: The application discloses a pipeline annular self-traveling guide apparatus and a pipeline annular self-traveling guiding method. The pipeline annular self-traveling guide apparatus includes an inner annular groove and an outer annular groove. A first pipeline fixing part is configured on the inner annular groove, a second pipeline fixing part is configured on the outer annular groove, an annular bracket which is configured to rotate freely along a circumferential direction is correspondingly configured between the inner annular groove and the outer annular groove, a pipeline supporting roller group is configured on the annular bracket, and gaps for laying pipelines are reserved between a circumferential surface of the pipeline supporting roller and inner bottom surfaces of the inner annular groove and the outer annular groove.

Abstract: The present invention provides a combination of an ERK1/2 inhibitor compound, 6,6-dimethyl-2-{2-[(1-methyl-1H-pyrazol-5-yl)amino]pyrimidin-4-yl}-5-[2-(morpholin-4-yl) ethyl]-5,6-dihydro-4H-thieno[2,3-c]pyrrol-4-one, or a pharmaceutically acceptable salt thereof with gemcitabine, or a pharmaceutically acceptable salt thereof preferably hydrochloride, or with gemcitabine, or a pharmaceutically acceptable salt thereof preferably hydrochloride, and nab-paclitaxel, and to methods of using the combination to treat certain disorders, such as pancreatic cancer, including pancreatic ductal adenocarcinoma (PDAC).

Abstract: The present invention relates to agonist antibodies that specifically bind to Notch 3 and activate signaling. The present invention includes antibodies binding to an epitope comprising the first Lin12 domain. The present invention also includes uses of these antibodies to treat or prevent Notch 3 related diseases or disorders.

Abstract: The present invention relates to agonist antibodies that specifically bind to Notch 3 and activate signaling. The present invention includes antibodies binding to an epitope comprising the first Lin12 domain. The present invention also includes uses of these antibodies to treat or prevent Notch 3 related diseases or disorders.

Abstract: The present invention relates to agonist antibodies that specifically bind to Notch 3 and activate signaling. The present invention includes antibodies binding to an epitope comprising the first Lin12 domain. The present invention also includes uses of these antibodies to treat or prevent Notch 3 related diseases or disorders.

Abstract: The present invention relates to agonist antibodies that specifically bind to Notch 3 and activate signaling. The present invention includes antibodies binding to an epitope comprising the first Lin12 domain. The present invention also includes uses of these antibodies to treat or prevent Notch 3 related diseases or disorders.

Abstract: The present invention relates to agonist antibodies that specifically bind to Notch 3 and activate signaling. The present invention includes antibodies binding to an epitope comprising the first Lin12 domain. The present invention also includes uses of these antibodies to treat or prevent Notch 3 related diseases or disorders.

Abstract: The present invention relates to agonist antibodies that specifically bind to Notch 3 and activate signaling. The present invention includes antibodies binding to an epitope comprising the first Lin12 domain. The present invention also includes uses of these antibodies to treat or prevent Notch 3 related diseases or disorders.

Abstract: The present invention relates to agonist antibodies that specifically bind to Notch 3 and activate signaling. The present invention includes antibodies binding to an epitope comprising the first Lin12 domain. The present invention also includes uses of these antibodies to treat or prevent Notch 3 related diseases or disorders.

Abstract: The present invention relates to agonist antibodies that specifically bind to Notch 3 and activate signaling. The present invention includes antibodies binding to an epitope comprising the first Lin12 domain. The present invention also includes uses of these antibodies to treat or prevent Notch 3 related diseases or disorders.